Pre-order Enquiry
Request Free Sample
Global and United States Enalapril Market Report & Forecast 2022-2028
SKU ID : QYR-20768547 | Publishing Date : 21-Apr-2022 | No. of pages : 110
Enalapril is used to treat hypertension, symptomatic heart failure, and asymptomatic left ventricular dysfunction.[9] It has been proven to protect the function of the kidneys in hypertension, heart failure, and diabetes, and may be used in the absence of hypertension for its kidney protective effects.[10] It is widely used in chronic kidney failure.[11] Furthermore, enalapril is an emerging treatment for psychogenic polydipsia.
Market Analysis and Insights: Global and United States Enalapril Market
This report focuses on global and United States Enalapril market, also covers the segmentation data of other regions in regional level and county level.
Due to the COVID-19 pandemic, the global Enalapril market size is estimated to be worth US$ million in 2022 and is forecast to a readjusted size of US$ million by 2028 with a CAGR of % during the review period. Fully considering the economic change by this health crisis, by Type, 2.5mg accounting for % of the Enalapril global market in 2021, is projected to value US$ million by 2028, growing at a revised % CAGR in the post-COVID-19 period. While by Application, Hospital was the leading segment, accounting for over percent market share in 2021, and altered to an % CAGR throughout this forecast period.
In United States the Enalapril market size is expected to grow from US$ million in 2021 to US$ million by 2028, at a CAGR of % during the forecast period.
Global Enalapril Scope and Market Size
Enalapril market is segmented by region (country), players, by Type and by Application. Players, stakeholders, and other participants in the global Enalapril market will be able to gain the upper hand as they use the report as a powerful resource. The segmental analysis focuses on revenue and forecast by region (country), by Type and by Application for the period 2017-2028.
For United States market, this report focuses on the Enalapril market size by players, by Type and by Application, for the period 2017-2028. The key players include the global and local players, which play important roles in United States.
Segment by Type
2.5mg
5mg
10mg
20mg
Segment by Application
Hospital
Drugs Store
By Region
North America
United States
Canada
Europe
Germany
France
U.K.
Italy
Russia
Asia-Pacific
China
Japan
South Korea
India
Australia
China Taiwan
Indonesia
Thailand
Malaysia
Latin America
Mexico
Brazil
Argentina
Middle East & Africa
Turkey
Saudi Arabia
UAE
By Company
Apotex Inc
Apothecon Inc Div Bristol Myers Squibb
Ivax Pharmaceuticals Inc Sub Teva Pharmaceuticals Usa
Krka Dd Novo Mesto
Lek Pharmaceuticals D D
Mylan Pharmaceuticals Inc
Ranbaxy Laboratories Ltd
Sandoz Inc
Taro Pharmaceutical Industries Ltd
Teva Pharmaceuticals Usa Inc
Watson Laboratories Inc
Wockhardt Americas Inc
Biovail Laboratories International Srl
Bedford Laboratories Div Ben Venue Laboratories Inc
Hikma Farmaceutica (Portugal) Sa
Hospira Inc
Teva Parenteral Medicines Inc
Market Analysis and Insights: Global and United States Enalapril Market
This report focuses on global and United States Enalapril market, also covers the segmentation data of other regions in regional level and county level.
Due to the COVID-19 pandemic, the global Enalapril market size is estimated to be worth US$ million in 2022 and is forecast to a readjusted size of US$ million by 2028 with a CAGR of % during the review period. Fully considering the economic change by this health crisis, by Type, 2.5mg accounting for % of the Enalapril global market in 2021, is projected to value US$ million by 2028, growing at a revised % CAGR in the post-COVID-19 period. While by Application, Hospital was the leading segment, accounting for over percent market share in 2021, and altered to an % CAGR throughout this forecast period.
In United States the Enalapril market size is expected to grow from US$ million in 2021 to US$ million by 2028, at a CAGR of % during the forecast period.
Global Enalapril Scope and Market Size
Enalapril market is segmented by region (country), players, by Type and by Application. Players, stakeholders, and other participants in the global Enalapril market will be able to gain the upper hand as they use the report as a powerful resource. The segmental analysis focuses on revenue and forecast by region (country), by Type and by Application for the period 2017-2028.
For United States market, this report focuses on the Enalapril market size by players, by Type and by Application, for the period 2017-2028. The key players include the global and local players, which play important roles in United States.
Segment by Type
2.5mg
5mg
10mg
20mg
Segment by Application
Hospital
Drugs Store
By Region
North America
United States
Canada
Europe
Germany
France
U.K.
Italy
Russia
Asia-Pacific
China
Japan
South Korea
India
Australia
China Taiwan
Indonesia
Thailand
Malaysia
Latin America
Mexico
Brazil
Argentina
Middle East & Africa
Turkey
Saudi Arabia
UAE
By Company
Apotex Inc
Apothecon Inc Div Bristol Myers Squibb
Ivax Pharmaceuticals Inc Sub Teva Pharmaceuticals Usa
Krka Dd Novo Mesto
Lek Pharmaceuticals D D
Mylan Pharmaceuticals Inc
Ranbaxy Laboratories Ltd
Sandoz Inc
Taro Pharmaceutical Industries Ltd
Teva Pharmaceuticals Usa Inc
Watson Laboratories Inc
Wockhardt Americas Inc
Biovail Laboratories International Srl
Bedford Laboratories Div Ben Venue Laboratories Inc
Hikma Farmaceutica (Portugal) Sa
Hospira Inc
Teva Parenteral Medicines Inc
Frequently Asked Questions
This market study covers the global and regional market with an in-depth analysis of the overall growth prospects in the market. Furthermore, it sheds light on the comprehensive competitive landscape of the global market. The report further offers a dashboard overview of leading companies encompassing their successful marketing strategies, market contribution, recent developments in both historic and present contexts.
- By product type
- By End User/Applications
- By Technology
- By Region
The report provides a detailed evaluation of the market by highlighting information on different aspects which include drivers, restraints, opportunities, and threats. This information can help stakeholders to make appropriate decisions before investing.
Request Sample
Request Discount
